HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.
暂无分享,去创建一个
M. Ladanyi | M. Kris | W. Pao | M. Arcila | Gregory Riely | V. Miller | K. Politi | Y. Janjigian | E. de Stanchina | V. Pirazzoli | K. Takezawa | Xiaoling Song | K. Ohashi | C. Nebhan | M. Melnick | P. Spitzler